Simple breath test could revolutionize lung cancer screening

NCT ID NCT07426718

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a device called Inflammacheck that measures chemicals in a person's breath to see if it can help tell the difference between lung cancer, other lung diseases, and healthy lungs. Researchers will collect breath samples from 140 adults and use AI to build a diagnostic model. If it works, this could become a quick, painless way to triage patients with breathing symptoms and catch lung cancer earlier.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could provide a simple, non-invasive breath test to help doctors quickly identify who needs further testing for lung cancer, potentially catching more cases early.
What could go wrong
This is an early-stage observational study, not a treatment trial. The AI model may not perform as well in real-world settings, and the test is not yet proven to reduce deaths.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Portsmouth Hospitals University NHS Trust

    RECRUITING

    Portsmouth, Hampshire, PO6 3LY, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.